Quick Summary:
As the preimplantation genetic testing market continues to unfold globally, this unique report offers comprehensive insights into the arena. Imbued with qualitative and quantitative analysis, the report goes beyond basic data by not only charting historical trends from the past five years but also forecasting toward the close of the decade.
It shares a regional dissection of the market covering North America, South America, Asia & Pacific, Europe, and MEA. Emphasizing key markets like the United States, China, Japan, India, and the larger European territories, it also encompasses a range of competitor data from global players to smaller, niche setups. The report presents an accurate reflection of the changing competitive landscape. Further, it houses an exclusive SWOT analysis, sales volume, revenue, price, and gross margin data for each company. With literature on both, key Preimplantation Genetic Testing applications and types, this report is a crucial tool for informed decision-making for senior executives.
For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.
This report covers the following regions:
- North America
- South America
- Asia & Pacific
- Europe
- MEA
The information for each competitor includes:
- Company Profile
- Main Business Information
- SWOT Analysis
- Sales Volume, Revenue, Price and Gross Margin
- Market Share
Applications Segment:
- Maternity Centers & Fertility Clinics
- Hospitals
Types Segment:
- Preimplantation Genetic Screening
- Preimplantation Genetic Diagnosis
Companies Covered:
- Abbott Laboratories
- Thermo Fisher Scientific
- Natera
- Illumina
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Abbott Laboratories
- Thermo Fisher Scientific
- Natera
- Illumina
- Perkin Elmer
Methodology
LOADING...
